Advances in CNS Drugs. Recent advances and considerations in the treatment of schizophrenia.
D000544:Alzheimer Disease / Q000188:drug therapy; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D003024:Clozapine / Q000627:therapeutic use; D004311:Double-Blind Method; D016527:Drug Costs; D015507:Drugs, Investigational / Q000191:economics; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D013830:Thiadiazoles / Q000627:therapeutic use
D014150:Antipsychotic Agents; D015507:Drugs, Investigational; D010919:Placebos; D011725:Pyridines; D013830:Thiadiazoles; D001569:Benzodiazepines; D010890:Pirenzepine; C075257:xanomeline; D003024:Clozapine; D000077152:Olanzapine